HK91993A - Compositions containing prostaglandins - Google Patents

Compositions containing prostaglandins Download PDF

Info

Publication number
HK91993A
HK91993A HK919/93A HK91993A HK91993A HK 91993 A HK91993 A HK 91993A HK 919/93 A HK919/93 A HK 919/93A HK 91993 A HK91993 A HK 91993A HK 91993 A HK91993 A HK 91993A
Authority
HK
Hong Kong
Prior art keywords
pge
gels
composition according
compound
gel
Prior art date
Application number
HK919/93A
Other languages
English (en)
French (fr)
Inventor
Brian Samuel Johnson
Original Assignee
Upjohn Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Limited filed Critical Upjohn Limited
Publication of HK91993A publication Critical patent/HK91993A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (10)

1. Eine pharmazeutisch annehmbare Zusammensetzung in der Form eines freifliessenden Gels, welches eine PGE Verbindung, kolloidales Siliciumdioxid und eine stabilisiernde organische Flüssigkeit umfasst.
2. Eine Zusammensetznung nach Anspruch 1, worin die organische Flüssigkeit ein Glycerylester ist.
3. Eine Zusammensetzung nach Anspruch 2, worin das Glycerylester Triacetin ist.
4. Eine Zusammensetzung nach Anspruch 2, die zwischen 8 und 15 Gewichtsprozent des kolloidalen Siliciumdioxids umfasst.
5. Eine Zusammensetzung nach einem der Ansprüche 1 bis 4, worin die PGE Verbindung PGE2 ist.
6. Eine Zusammensetzung nach einem der Ansprüche 1 bis 4, worin die PGE Verbindung (15R)-15-Methyl-PGE2 ist.
7. Eine Zusammensetzung nach einem der Ansprüche 1 bis 4, worin die PGE Verbindung 16,16-dimethyl-PGE2 ist.
8. Eine Zusammensetzung nach einem der Ansprüche 1 bis 4, worin die PGE Verbindung (17S),20-Dimethyl-PGE2 ist.
9. Eine Zusammensetzung nach einem der Ansprüche 1 bis 4, worin die PGE Verbindung 15-Methyl-PGE2 ist.
10. Eine Zusammensetzung nach einem der Ansprüche 1 bis 4 worin die PGE Verbindung PGE, ist.
HK919/93A 1982-03-22 1993-09-02 Compositions containing prostaglandins HK91993A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8208322 1982-03-22

Publications (1)

Publication Number Publication Date
HK91993A true HK91993A (en) 1993-09-10

Family

ID=10529176

Family Applications (1)

Application Number Title Priority Date Filing Date
HK919/93A HK91993A (en) 1982-03-22 1993-09-02 Compositions containing prostaglandins

Country Status (9)

Country Link
US (1) US4680312A (de)
EP (1) EP0089768B1 (de)
JP (1) JPS58167509A (de)
DE (1) DE3381898D1 (de)
DK (1) DK167139B1 (de)
FI (1) FI81962C (de)
HK (1) HK91993A (de)
NO (1) NO163042C (de)
ZA (1) ZA831186B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277622A (ja) * 1985-05-31 1986-12-08 Teijin Ltd 活性型ビタミンｄ３類製剤用組成物
JP3756512B2 (ja) * 1992-09-21 2006-03-15 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 徐放性タンパク質製剤
US5939090A (en) 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
WO1999002147A1 (en) 1997-07-09 1999-01-21 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6593369B2 (en) 1997-10-20 2003-07-15 Vivus, Inc. Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US5877216A (en) * 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
US20050070516A1 (en) * 1997-10-28 2005-03-31 Vivus Inc. As-needed administration of an androgenic agent to enhance female desire and responsiveness
AU740758B2 (en) 1997-10-28 2001-11-15 Vivus, Inc. Treatment of female sexual dysfunction
US20020009478A1 (en) * 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
RU2223101C2 (ru) * 2001-10-04 2004-02-10 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия Набор для стимуляции родовой деятельности
EP2692360A4 (de) * 2011-03-31 2014-10-29 Fujifilm Corp Prostaglandinhaltige fettemulsion
ES2935528T3 (es) 2013-02-25 2023-03-07 Sun Pharmaceutical Ind Ltd Formulación y suspensión oral de un fármaco oncológico
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
CN107496348A (zh) * 2017-08-28 2017-12-22 天津昂赛细胞基因工程有限公司 一种用于组织损伤修复的水凝胶及制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (de) * 1970-06-10 1975-02-04
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3829579A (en) * 1971-11-01 1974-08-13 Upjohn Co Stable solutions of pge-type compounds
US3826823A (en) * 1972-09-25 1974-07-30 Syntex Inc Stabilized prostaglandin preparations
US3927197A (en) * 1974-04-19 1975-12-16 Pfizer Tertiary alcohol stabilized E-series prostaglandins
JPS51136818A (en) * 1975-05-20 1976-11-26 Yamanouchi Pharmaceut Co Ltd Method for preparing stable prostaglandine pharma ceuticals
US3966962A (en) * 1975-03-27 1976-06-29 The Upjohn Company Triacetin solutions of PGE-type compounds
JPS6043335B2 (ja) * 1976-05-21 1985-09-27 山之内製薬株式会社 安定なプロスタグランジンｅ類含有組成物
SE431821B (sv) * 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
US4211793A (en) * 1979-03-19 1980-07-08 American Cyanamid Company Triethyl citrate solutions of PGE-type compounds
AU537741B2 (en) * 1979-03-21 1984-07-12 British Technology Group Limited Controlled release compositions
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
JPS6033430B2 (ja) * 1980-05-12 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物

Also Published As

Publication number Publication date
EP0089768B1 (de) 1990-09-26
EP0089768A1 (de) 1983-09-28
FI830890A0 (fi) 1983-03-17
NO830988L (no) 1983-09-23
FI81962C (fi) 1991-01-10
NO163042B (no) 1989-12-18
US4680312A (en) 1987-07-14
FI81962B (fi) 1990-09-28
DK167139B1 (da) 1993-09-06
DK127883A (da) 1983-09-23
JPS58167509A (ja) 1983-10-03
DK127883D0 (da) 1983-03-21
ZA831186B (en) 1983-11-30
JPH0322850B2 (de) 1991-03-27
DE3381898D1 (de) 1990-10-31
FI830890L (fi) 1983-09-23
NO163042C (no) 1990-04-18

Similar Documents

Publication Publication Date Title
EP0089768B1 (de) Prostaglandin enthaltende Zusammensetzungen
US4888168A (en) Stable ophthalmic preparations containing acetazolamide
US4889845A (en) Vehicle for topical application of pharmaceuticals
US5192802A (en) Bioadhesive pharmaceutical carrier
US2703777A (en) Ophthalmological preparations and vehicles and method of making the same
KR100634571B1 (ko) 연질 젤라틴 제제용 약학 조성물의 제조 방법
EP0390369A2 (de) Oral verabreichbare Ibuprofen enthaltende Mittel
JPS62190119A (ja) 高粘度ヒドロゲル又は懸濁液を得るための製剤
EP0357030B1 (de) Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten
JPH10511364A (ja) 安定なブデゾナイド溶液、その製造方法並びに該溶液を浣腸剤及び医薬泡沫剤として使用する用途
JPH0140013B2 (de)
US4923862A (en) Topical preparation containing ofloxacin
EP0719548A1 (de) Gelierungsmittel für polyethylene Glycol
HU189736B (en) New suppository base ensuring steady active substance release
US5378470A (en) Rectally administered pharmaceutical preparation
JP2011241211A (ja) コルチコステロイドを含有するスティックタイプの局所製剤
PT706380E (pt) Farmaco encapsulado
US2637679A (en) Intramuscularly-administrable prolonged-action penicillin products
CA1249223A (en) Solid drug formulations and stable suspensions
DE2611183A1 (de) Stabile dosierungsform von prostaglandinartigen verbindungen
CZ277775B6 (en) Process for preparing ethopside agent
CA1180276A (en) Gelled pge.sub.2/triacetin solutions
US3325366A (en) Biologically absorbable foam packing bandage and process therefor
US4032645A (en) Injectable metronidazole composition
EP0436015B1 (de) Pharmazeutische zubereitung zur rektalen verabreichung

Legal Events

Date Code Title Description
PE Patent expired